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Human tissue inhibitor of mctalloproteinascs-I (TIMP-I), but not TlMP-2, has potent growth-promoting activity for a wide range of human and 
bovine cells, TLMP-1 seems to be a new cell-growth factor in serum and to stimulate the cells indcpendcntly of its inhibilory activity. 
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I. INTRODUCTION 2. MATERIALS AND METHODS 
The tissue inhibitor of mctalloproteinases-1 (TIMP- 
I), a sialoglycoprotein with a molecular weight oT 
around 30,000, is a specific inhibitor of matrix metal- 
loproteinascs (MMPs) such as interstitial collagenase, 
gelatinaseitype IV collagenase (72 kDa and 92 kDa) and 
stromelysin, but not for metalloproteinases such as bac- 
terial collagenase and thermolysin [I]. TIMP-I is 
produced by various kinds of cells and found in every 
human body fluid examined [2,3], suggesting that 
TlMP-I is a fundamental and ubiquitous protein in 
human beings. The amino acid sequence [4] of TIMP-I 
deduced from its cDNA analysis is known to be identi- 
cal to that of erythroid potcntiating activity (EPA) [5], 
which stimulates the growth of erythroid precursors 
(BFU-E and CFU-E) [6] and the K-S62 human erythro- 
leukemia cell line [7]. We recently demonstrated that 
TIMP-I produced by human bone marrow stromal cell 
line KH 102 stimulated the colony formation of BFU-E 
and CFU-E [S]. These findings prompted us to investi- 
gate the possibility that TIMP-1 possesses growth- 
factor activity for other cells besides erythroid precursor 
cells. Here we report that human TIMP-1 has potent 
growth-promoting activity for a wide range of cells and 
provide some facts .that support the proposition that 
TIMP-1 is a new cell-growth factor in serum. 
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Dulbccco’s modified Eagle’s minimal crscntial medium (D-MEM) 
was purchased from Gibco Laboratories, Grand island, NY, USA. 
RPM1 1640 mlxiium was from Flow Laboratories, Irvine, Scotland, 
UK. ASF-104, an albumin-free culture medium. was from Ajinomoto 
Ltd., Tokyo. Fetal calf serum (FCS) was from Bio Cell, Carson, CA, 
USA. 
The following cell lines were supplied by ihc Japanese Cancer 
Research Resources Bank (JCRB) and cultured in JCRB- 
recommended media: human lymphoblasts. non-secreting variant 
(WILZ-NS); human cry:!ircIeu!cz.ia cells (K-562). human myc- . 
Iogcncous Ieukcmiacclls (HL60); bovine pulmonary artery cndothclial 
cells (CPA); Burkitt lymphoma cell lines Daudi and Ramos; human 
hepatoma cells (HLE). Human gingival fibrobiasls (Sin-l). SY40- 
transformed human lung cells (WI-38YA13). and human skin cpi- 
thclial cells (NCTC 2544) wcrc purchased from the Amcrian Type 
Culture Collection. Rockvillc. MD. USA. Raji cells were gcncrously 
provided by Dr. Shonen Yoshida (Research Institute for Disease 
Mechanism and Control, Nagoya University School of Medicine, 
Nagoya, Japan). Human aortic smooth muscle cells (HSM) were a 
kind gift of Dr. Yasuyuki Sasaguri (Department of Pathology. 
Kurumc University School of Medicine, Kurumc. Japan). Human 
breast adenocarcinoma cells (MCF7) were a generous gift of Dr. Shuji 
Yamamoto (Bio-Science Laboratory, Life Science Rczcareh Labo- 
ratories, Asahi Chemical Industry Co., Fuji-City, Shizuoka, Japan). 
Bovine articular chondrocyles (BAC) were a generous gift from 
Marllho Co., Osaka, Japan. 
2.3. Herman TIM&V uttd TIMP-2 prcparuriorts 
Natural (n)TIMP-I was purified in a homogeneous form from Gin- 
I eell-conditioned medium as reported previously [9]. Recombinant 
(r)TIMP-1 that was expressed in a mouse Fibroblast (Cl27) eelI lint 
and purified to more than 95% iI O] was purchased from Celltech. Ltd.. 
Slough. UK. nTIMP-2 was purllied as described [I I]. 
2.4. Preparation of TIMP-i-free FCS 
TIMP-l-free FCS was prepared by the passas of FCS throua an 
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Fig. I. Effect of TIMP addition on tire growth of cells cultured in serum-free synthetic medium. The concentration of either human natural (n) 
TlMPs (TIMP-I and TIMP-9) or human recombinant (r) TIMP-I was 100 t-&ml (3.6 nM). DNA content at day 3 was determined with Burkitt 
lymphoma cdl line Raji und at day 7 with human gingival fibroblasts (Gin-l). Results arc the meun of three experiments, with standard deviation. 
anti-TIMP-I monoclonal antibody-Sepharose aflinity column [9] to 
remove TIMP-I, and then stcrilizcd by passage through a FALCON 
7104 bottle stop filter (0.40pm. Becton Dickinson, Lincoln Park, NJ, 
USA), 
2.5. Deternlinatiot~ OJ TIMP-I rrttrl DNA co~~uc~~~ru~i~t~s 
The TIMP-I concentration was determined by a sandwich enzyme 
immunoassay [I’]. DNA contents were determined by the method 
reported by Hinyardner [ 131. 
3. RESULTS AND DISCUSSION 
We first examined the effect of TIMP-I addition on 
the growth of human gingival fibroblasts (Gin-l) and 
Burkitt lymphoma cell line Raji cultured in serum-free 
synthetic media (Fig. 1). Neither cell line was able to 
gro.w in basal media such as Dulbecco’s modified 
Eagle’s minimal essential medium (D-MEM) and 
RPM1 1640 medium. The cells, however, grew signifl- 
cantly in those basal media supplemented with 100 ng/ 
ml (3.6 nM) of highly purified human natural (n)TIMP- 
1. Human recombinant (r)TIMP-1 had the same 
growth-promoting activity as nTIMP-1. This strongly 
supports our hypothesis that the growth-promoting ac- 
tivity can be ascribed to TIMP-1 alone. In enriched 
media such as ASF-104, both cells proliferated to a 
certain extent. Mowever, both nTlMP-01 and rTIMP-1 
significantly stimulated the cell growth up to the level 
close to that in 10% FCS. As Raji cells do not secrete 
MMPs, TIMP-1 seems to stimulate the cells independ- 
ently of its inhibitory activity. 
Recentiy, a now member of the metalloproteinasc in- 
hibitor family, TIMP-2, was reported [ 11,14-173. 
TIMP-2 has a spectrum of antimetalloproteinase ac- 
tivities similar to that. of TIMP-1 but differs from 
30 
TIMP-I in that it is unglycosylated and bound to the 
proenzyme form of 72-kDa gelatinase/type IV col- 
lagenase [16]. TIMP-2 is also clearly distinguished from 
TIMP-1 by not reacting with monospecific anti-TIM&l 
antibodies [14,17]. It has been recently reported that 
TIMP-2 regulates the autoactivation of interstitial col- 
lagenase [181 and 7%kDa gelatinase [191, and preferen- 
tially inhibits 72-kDa and 92.kDa gelatinases [20]. As 
shown in Fig. 1, TIMP-2 did not have any cell growth- 
promoting activity, thus demonstrating that there is a 
definite difference in the physiological role between 
TTMP-1 and TIMP-2. This result further supports the 
fact that the cell-proliferating activity of TlMP-1 is not 
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Fig. 2. TIMP-l-dependent proliferation of human gingival fibroblasts. 
The IO% FCS in the absence of cells contained 34.1 q//ml TIMP-1. 
Results arc the mean ofthree lo six experiments. with standard devia- 
tion. 
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that TIM&l has a sequence homologous with human one or more further unknown serum factors may play 
granulocyte-macrophagc colony-stimulating factor key roles in regulating in vivo cell maintenance and 
(GM-CSF) in the N-terminal domain [21] but that proliferation. TIMP-1 may be such a factor. 
TIMP-2 has no such sequence. This is consistent with When anti-TIMP-1 monoclonal antibodies (clone 7- 
the degrees of cell-growth promoting activity of both 6CI) [9] were added to theculture medium of Gin-l cells, 
TIMPs mentioned above. almost complete suppression of cell growth was ob- 
We have already reported that the TIMP-1 con- served in the presence of 2 &ml antibody (data not 
centration in human serum is 183 z!z 30 (mean -I- S.D.) shown). We next examined whether the cells might grow 
ng/ml [3]. TIMP-1 concentrations in 29 fetal calf serum in TIMP-l-free FCS. As shown in Fig. 2, the cell pro- 
(FCS) samples obtained from several different distrib- liferation was suppressed remarkably in TIMP-l-free 
utors ranged from 100 to 460 @ml (mean f SD., 213 FCS. The growth was, however, fully restored bj the 
!: 79). Although several chemically defined synthetic addition of nTlMP-1 or r TIMP-1 to the culture system. 
media have been developed, the requirement for serum All the TIMP-1 (100.4 f. 7.8 ndml) detected in TIMP- 






l-free FCS culture medium was surely produced by the 
T 
NCTC 2544 WI=38VA13 MCF7 
J 
WIL2.NS K.562 HL60 Raji Ramus Daudi 
nOBY q TIMP-141~ FCS 
n 10% KS (20% Car CPA) q TIMP-l-free FCS + lOOng/ml nTIMP-I (2OOngIml for CPA) 
Fig. 3. TIMP-1 -dependency of cell proliferation of various lypos of cells. DNA content at day 7 for adherent cells (a) and at day 2 for non-adherent 
cells (b) was dcrerminci. Resuits arr he mean ofthrs ciiprimcnis, with standard dcvhtioc. . . uS??‘., hc:nsn zor!ic smooth muscle cells; CPA, bwinc 
pulmonary arlery endothclial cells; I)AC, bovine articular chondrocytcs; NCTC 2544, human skin cpithelial cells; WI-38VAI 3, SV4OGansformcd 
human lungcells; MCF7, human breast adenocarcinomncells; WILZ-NS, human lymphoblasts; K-562, humanerythroleukcmiacclls; HL60, human 
myelogeneous leukemia cells; Raji, Ramos, and Daudi. i3urkitt lymphoma cell lines. 
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cells themselves. The cell proliferation was completely 
suppressed by a limited amount (54 ng/ml) of anti- 
TIMP-1 monoclonal antibody (clone 7-SCl) added to 
TIMP-l-free FCS-containing cultures from the begin- 
ning to trap the newly synthesized TIMP-1 (data not 
shown). These findings strongly suggest that TIMP-1 
produced by the cells themselves certainly stimulates 
their proiiferation by either an autocrine or paracrine 
mechanism. As is evident from Fig. 2, the TIMP-I con- 
tent in the culture medium supplemented with rTIMP-1 
was significantly low (PcO.05) compared with that in 
medium supplemented with the same amount of 
nTIMP-I. We found that some metalloproteinase(s) 
produced by Gin-l cells during the 7-day culture, selec- 
tively acted on rTIMP-1 and made it insensitive to the 
sandwich enzyme immunoassay for TIMP-1 (data not 
shown). 
The question then arose as to whether the growth- 
promoting activity of TIMP- I was limited to some spe- 
cific cells like Gin-l cells. To answer this question, we 
examined the TIMP-I dependency of cell proliferation 
with several human and bovine adherent and non- 
adherent cells. It appeared that the growth of all the 
cells examined was significantly dependent on TIMP-1 
(Fig. 3). However, the growth of human aortic smooth 
muscle cells (HSM) was not fully restored by the addi- 
tion of human TIMP-1. SV40-transformed human lung 
cells (WL38VA13) grew quite well even in TIMP-l-free 
FCS. EPA, which has been revealed to stimulate specif- 
ically the proliferation of erythroid progenitor cells and 
K- 562 cells, can now be considered to be one aspect of 
the general cell growth-promoting activity of TIMP- 1. 
It is intriguing that TIMP-1 appears to be a single 
glycoprotein with both protease inhibitory activity and 
growth-promoting activity. In the case of adherent cells, 
for which the extracellular matrix is essential both struc- 
turally and functionally, we can easily understand that 
TIMP-1 has an important role, on the one hand, for the 
maintenance of extracellular matrix integrity and, on 
the other hand, for the proliferation of these cells in 
either autocrine or paracrine fashion. Even in the case 
of non-adherent cells, especially in the in viva situation, 
the differentiation and proliferation of these cells might 
depend on their interaction with the surrounding en- 
vironment. Actually, it is well recognized that the he- 
matopoietic microenvironment plays an important part 
in the differentiation and prolifizration of ,blood cells 
[22]. In view of the above, it is not illogical that TIMP-1 
has both protease inhibitory activity and growth- 
promoting activity. Similar examples like endotheliai 
cell growth factors 2a and 2b (ECGF-2a and -2b) have 
already been repjrted [23], which also have protease 
inhibitory activities. An investigation into the mecha- 
nism of the growth-promoting activity of TIMP-1, such 
as the search for a TlMP-1 receptor, is now underway 
in our laboratory. 
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